To validate the similar phenomena in GBM, we chronically activated type I and type II IFN signaling in GSCs with no to low basal levels of IFN signaling using recombinant IFNs for 2 weeks followed by 1 week of washing (no treatment). The gene discussed is IFNA1; the disease is glioblastoma.